# Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172

> **NCT01222351** · NA · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 161 (actual)

## Conditions studied

- Late Onset Alzheimer Disease

## Interventions

- **DRUG:** BAY 94-9172 (Florbetaben)

## Key facts

- **NCT ID:** NCT01222351
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2014-10-22
- **Final completion:** 2014-10-22
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2024-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01222351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01222351, "Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01222351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*